SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17621181
Source:
http://linkedlifedata.com/resource/pubmed/id/17621181
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0087111
,
umls-concept:C0271084
,
umls-concept:C0920367
,
umls-concept:C1531015
,
umls-concept:C2607943
,
umls-concept:C2926606
pubmed:issue
6
pubmed:dateCreated
2007-7-10
pubmed:abstractText
To evaluate macular thickness measured by optical coherence tomography (OCT) during pegaptanib therapy for neovascular age-related macular degeneration (AMD).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309919
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Aptamers, Nucleotide
,
http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
,
http://linkedlifedata.com/resource/pubmed/chemical/pegaptanib
pubmed:status
MEDLINE
pubmed:issn
0275-004X
pubmed:author
pubmed-author:EmersonGeoffrey GGG
,
pubmed-author:EmersonM VaughnMV
,
pubmed-author:FlaxelChristina JCJ
,
pubmed-author:KleinMichael LML
,
pubmed-author:LauerAndreas KAK
,
pubmed-author:NolteSusanS
,
pubmed-author:StoutJ TimothyJT
,
pubmed-author:WilsonDavid JDJ
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
724-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17621181-Aged
,
pubmed-meshheading:17621181-Aged, 80 and over
,
pubmed-meshheading:17621181-Angiogenesis Inhibitors
,
pubmed-meshheading:17621181-Aptamers, Nucleotide
,
pubmed-meshheading:17621181-Choroidal Neovascularization
,
pubmed-meshheading:17621181-Female
,
pubmed-meshheading:17621181-Fluorescein Angiography
,
pubmed-meshheading:17621181-Follow-Up Studies
,
pubmed-meshheading:17621181-Fovea Centralis
,
pubmed-meshheading:17621181-Humans
,
pubmed-meshheading:17621181-Injections
,
pubmed-meshheading:17621181-Macular Degeneration
,
pubmed-meshheading:17621181-Macular Edema
,
pubmed-meshheading:17621181-Male
,
pubmed-meshheading:17621181-Middle Aged
,
pubmed-meshheading:17621181-Prospective Studies
,
pubmed-meshheading:17621181-Tomography, Optical Coherence
,
pubmed-meshheading:17621181-Vascular Endothelial Growth Factor A
,
pubmed-meshheading:17621181-Vitreous Body
pubmed:articleTitle
Optical coherence tomography findings during pegaptanib therapy for neovascular age-related macular degeneration.
pubmed:affiliation
Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't